Trade with Eva : Analytics in action: =Abbott Labs (ABT) reported 4Q earnings on Thur 28 Jan 2016 (before open)

Thursday, January 28, 2016

** charts before earnings **

** charts after earnings **

Abbott Labs beats by $0.01, misses on revs; guides Q1 EPS below consensus; guides FY16 EPS below consensus :

7Reports Q4 (Dec) earnings of $0.62 per share, $0.01 better than the Capital IQ Consensus of $0.61; revenues fell 3.1% year/year to $5.19 bln vs the $5.25 bln Capital IQ Consensus.
Co issues downside guidance for Q1, sees EPS of $0.38-0.40 vs. $0.48 Capital IQ Consensus Estimate.
Co issues downside guidance for FY16, sees EPS of 2.10-2.20 vs. $2.30 Capital IQ Consensus Estimate.
Abbott's 2016 forecast assumes a significantly lower contribution from Venezuelan operations as a result of challenging market conditions in that country. Excluding the impact of foreign exchange and Venezuela, the midpoint of Abbott's 2016 adjusted EPS guidance range would reflect strong double-digit growth.